413 related articles for article (PubMed ID: 21533533)
1. PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome.
Atis A; Aydin Y; Basol E; Kaleli S; Turgay F; Goker N
Arch Gynecol Obstet; 2012 Jan; 285(1):45-9. PubMed ID: 21533533
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity.
Ozler A; Turgut A; Sak ME; Evsen MS; Soydinc HE; Evliyaoglu O; Gul T
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1707-12. PubMed ID: 23161044
[TBL] [Abstract][Full Text] [Related]
3. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome.
Gul A; Cebeci A; Aslan H; Polat I; Ozdemir A; Ceylan Y
Gynecol Obstet Invest; 2005; 59(2):113-8. PubMed ID: 15591806
[TBL] [Abstract][Full Text] [Related]
4. [Difference between preeclampsia, HELLP syndrome and eclampsia, maternal evaluation].
Vigil-de Gracia PE; Tenorio-Marañón FR; Cejudo-Carranza E; Helguera-Martínez A; García-Cáceres E
Ginecol Obstet Mex; 1996 Aug; 64():377-82. PubMed ID: 8925990
[TBL] [Abstract][Full Text] [Related]
5. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome.
Miranda ML; Macher HC; Muñoz-Hernández R; Vallejo-Vaz A; Moreno-Luna R; Villar J; Guerrero JM; Stiefel P
Am J Hypertens; 2013 Dec; 26(12):1377-80. PubMed ID: 24103646
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester.
Deveci K; Sogut E; Evliyaoglu O; Duras N
J Obstet Gynaecol Res; 2009 Feb; 35(1):94-8. PubMed ID: 19215554
[TBL] [Abstract][Full Text] [Related]
7. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
[TBL] [Abstract][Full Text] [Related]
8. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
[TBL] [Abstract][Full Text] [Related]
9. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease].
Chavarría Olarte ME; González Gleason A; Lara González AL; Sojo Aranda I; García Paleta Y; Vital Reyes VS; Reyes Fuentes A
Ginecol Obstet Mex; 2000 Sep; 68():385-93. PubMed ID: 11080945
[TBL] [Abstract][Full Text] [Related]
10. Comparison of placental pathology between severe preeclampsia and HELLP syndrome.
Mehrabian F; Mohammadizadeh F; Moghtaderi N; Najafian A
Arch Gynecol Obstet; 2012 Jan; 285(1):175-81. PubMed ID: 21698449
[TBL] [Abstract][Full Text] [Related]
11. Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption.
Ranta JK; Raatikainen K; Romppanen J; Pulkki K; Heinonen S
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):48-52. PubMed ID: 21482016
[TBL] [Abstract][Full Text] [Related]
12. [Factors related to the diagnosis of HELLP syndrome in patients with severe preeclampsia].
Villanueva Egan LA; Bohórquez Barragán ME; Alanís López P
Ginecol Obstet Mex; 2004 Aug; 72():394-9. PubMed ID: 15526555
[TBL] [Abstract][Full Text] [Related]
13. [Plasma VEGF levels are increased in women with severe preeclampsia or HELLP syndrome].
Bussen S; Rieger L; Sütterlin M; Dietl J
Z Geburtshilfe Neonatol; 2003; 207(3):101-6. PubMed ID: 12891468
[TBL] [Abstract][Full Text] [Related]
14. [Low PAPP-A levels between 11 and 13(+6) weeks of gestation and the risk of preeclampsia].
Stoykova V; Vagarova R; Markov D; Kremensky I; Ivanov S
Akush Ginekol (Sofiia); 2010; 49(6):19-25. PubMed ID: 21427871
[TBL] [Abstract][Full Text] [Related]
15. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
[TBL] [Abstract][Full Text] [Related]
16. [Maternal and perinatal surgical complications in low platelet count for HELLP syndrome in severe preeclampsia-eclampsia in intensive care].
Basavilvazo Rodríguez A; Pacheco Pérez C; Lemus Rocha R; Martínez Pérez JM; Martínez Martínez A; Hernández-Valencia M
Ginecol Obstet Mex; 2003 Aug; 71():379-86. PubMed ID: 14619691
[TBL] [Abstract][Full Text] [Related]
17. Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.
Luewan S; Teja-Intr M; Sirichotiyakul S; Tongsong T
Singapore Med J; 2018 Jan; 59(1):55-59. PubMed ID: 28451695
[TBL] [Abstract][Full Text] [Related]
18. A clinicohistopathologic comparison between HELLP syndrome and severe preeclampsia.
Smulian J; Shen-Schwarz S; Scorza W; Kinzler W; Vintzileos A
J Matern Fetal Neonatal Med; 2004 Nov; 16(5):287-93. PubMed ID: 15621545
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of thrombospondin-1 are decreased in HELLP syndrome.
Stenczer B; Molvarec A; Szabó G; Szarka A; Fügedi G; Szijártó J; Rigó J
Thromb Res; 2012 Apr; 129(4):470-3. PubMed ID: 22035632
[TBL] [Abstract][Full Text] [Related]
20. Plasma IL-4, IL-8, IL-12, interferon-γ and CRP levels in pregnant women with preeclampsia, and their relation with severity of disease and fetal birth weight.
Cemgil Arikan D; Aral M; Coskun A; Ozer A
J Matern Fetal Neonatal Med; 2012 Sep; 25(9):1569-73. PubMed ID: 22185464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
